top of page

Mastering Cardiomyopathies for the MRCP (UK) Part 1: A Comprehensive Guide

  • Writer: Dr Izza Arsyika
    Dr Izza Arsyika
  • 7 days ago
  • 4 min read

Welcome! At MEDIT & CME Academy, we understand the challenges of preparing for the MRCP (UK) examinations. This blog post focuses on a crucial Cardiology topic: Cardiomyopathies, essential knowledge for your MRCP (UK) Part 1 exam.

We aim to provide a structured overview, equipping you with the necessary knowledge and confidence to tackle related questions. 

Understanding Cardiomyopathies: A Foundation for Success

Cardiomyopathies represent a diverse group of myocardial disorders where the heart muscle is structurally and functionally abnormal, in the absence of coronary artery disease, hypertension, valvular disease, or congenital heart disease sufficient to cause the observed myocardial abnormality.

For the MRCP (UK) exam, a solid understanding of their classification, pathophysiology, clinical presentation, and investigation is paramount.

Learning Outcomes: What You Need to Know

By the end of this guide, you should be able to:

  1. Define the types of cardiomyopathies (dilated, hypertrophic, restrictive, arrhythmogenic right ventricular cardiomyopathy, and unclassified forms) according to the appropriate guidelines.

  2. Describe the pathophysiological mechanisms underlying each cardiomyopathy, including genetic mutations, myocardial fibrosis, and structural remodelling.

  3. Recognize the clinical features of cardiomyopathies, such as dyspnea, syncope, palpitations, chest pain, and sudden cardiac death.

  4. Identify key physical examination findings, such as displaced apex beat in dilated cardiomyopathy or systolic ejection murmur in hypertrophic cardiomyopathy.

  5. Understand the genetic basis of hereditary cardiomyopathies and the importance of family screening.

  6. Interpret basic diagnostic tests, including echocardiography, ECG abnormalities, and chest X-rays, in patients with suspected cardiomyopathies.

  7. Explain the role of common causes, such as alcohol, viral infections, and systemic diseases (e.g., sarcoidosis or amyloidosis), in acquired cardiomyopathies.

Types of Cardiomyopathies: A Detailed Examination

An image showing the 4 types of cardiomyopathies and its respective descriptions/characteristics.
Types of Cardiomyopathies

🫀Dilated Cardiomyopathy (DCM)

DCM is characterized by dilation and impaired contraction of the left ventricle or both ventricles. Key points for the MRCP exam include:

  • Pathophysiology: Often idiopathic, but can be due to genetic mutations, alcohol abuse, viral infections (e.g., Coxsackievirus), pregnancy, and certain medications. Myocardial fibrosis and chamber enlargement are hallmarks.

  • Clinical Features: Heart failure symptoms (dyspnea, fatigue, edema), arrhythmias, and thromboembolic events.

  • Physical Exam: Displaced apex beat, S3 gallop, and signs of heart failure (e.g., elevated jugular venous pressure, peripheral edema).

  • Investigations: Echocardiography is crucial, showing dilated ventricles and reduced ejection fraction. ECG may show left bundle branch block or atrial fibrillation. Consider ruling out coronary artery disease.

🫀Hypertrophic Cardiomyopathy (HCM)

HCM is characterized by left ventricular hypertrophy, often asymmetrical, usually involving the interventricular septum.

  • Pathophysiology: Most commonly caused by genetic mutations affecting sarcomeric proteins. Diastolic dysfunction and outflow obstruction (in some cases) are key features.

  • Clinical Features: Dyspnea, chest pain, syncope, palpitations, and sudden cardiac death (particularly in young athletes).

  • Physical Exam: Systolic ejection murmur that increases with Valsalva manoeuvre and standing (decreases with squatting). May have a double apical impulse.

  • Investigations: Echocardiography shows left ventricular hypertrophy. ECG may show T-wave inversions and Q waves. Cardiac MRI can be helpful in cases with diagnostic uncertainty.

🫀Restrictive Cardiomyopathy (RCM)

RCM is characterized by impaired ventricular filling due to increased stiffness of the myocardium. Key considerations for the MRCP exam:

  • Pathophysiology: Can be idiopathic or due to infiltrative diseases (e.g., amyloidosis, sarcoidosis), storage diseases (e.g., hemochromatosis), or fibrosis.

  • Clinical Features: Heart failure symptoms, particularly right-sided (e.g., peripheral edema, ascites), fatigue, and dyspnea.

  • Physical Exam: Elevated jugular venous pressure, hepatomegaly, and peripheral edema. May have a prominent S4 gallop.

  • Investigations: Echocardiography may show normal or slightly reduced ventricular size with normal systolic function but impaired diastolic filling. Endomyocardial biopsy may be needed to confirm the diagnosis. Cardiac MRI can help identify infiltrative processes.

🫀 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

ARVC is characterized by fibrofatty replacement of the right ventricular myocardium, predisposing to ventricular arrhythmias. Important for the MRCP (UK):

  • Pathophysiology: Primarily a genetic disorder affecting desmosomal proteins.

  • Clinical Features: Palpitations, syncope, and sudden cardiac death (often during exercise).

  • Physical Exam: Often unremarkable. May have signs of right ventricular dysfunction.

  • Investigations: ECG may show epsilon waves and T-wave inversions in the right precordial leads. Echocardiography may show right ventricular dilatation and dysfunction. Cardiac MRI is crucial for diagnosis.

Acquired Cardiomyopathies: Secondary Causes

Remember to consider secondary causes of cardiomyopathy for the MRCP exam. These include:

  • Alcoholic Cardiomyopathy: Due to chronic alcohol abuse.

  • Peripartum Cardiomyopathy: Develops during the last month of pregnancy or within five months postpartum.

  • Tachycardia-Induced Cardiomyopathy: Due to prolonged periods of rapid heart rate.

  • Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy): Characterized by transient left ventricular dysfunction triggered by emotional or physical stress.

Genetic Considerations and Family Screening

A significant proportion of cardiomyopathies are hereditary. Understanding the genetic basis and the importance of family screening is crucial for the MRCP (UK) Part 1. Patients with a family history of cardiomyopathy or sudden cardiac death should undergo genetic testing and cardiac evaluation.

Diagnostic Approach: ECG and Echocardiography

The ECG and echocardiogram are the cornerstone of cardiomyopathy diagnosis. Be familiar with the typical ECG and echocardiographic findings for each type of cardiomyopathy for the MRCP exam.

Further Learning

Mastering cardiomyopathies requires a thorough understanding of their classification, pathophysiology, clinical presentation, and investigation. We hope this guide has provided a valuable framework for your MRCP (UK) Part 1 preparation.


To further enhance your understanding and boost your chances of success, we encourage you to explore our comprehensive short course on Cardiology at CME Academy: Cardiology MRCP Part 1 Course.

bottom of page